» Articles » PMID: 28598979

Association of Maternal Weight with FADS and ELOVL Genetic Variants and Fatty Acid Levels- The PREOBE Follow-up

Abstract

Single nucleotide polymorphisms (SNPs) in the genes encoding the fatty acid desaturase (FADS) and elongase (ELOVL) enzymes affect long-chain polyunsaturated fatty acid (LC-PUFA) production. We aimed to determine if these SNPs are associated with body mass index (BMI) or affect fatty acids (FAs) in pregnant women. Participants (n = 180) from the PREOBE cohort were grouped according to pre-pregnancy BMI: normal-weight (BMI = 18.5-24.9, n = 88) and overweight/obese (BMI≥25, n = 92). Plasma samples were analyzed at 24 weeks of gestation to measure FA levels in the phospholipid fraction. Selected SNPs were genotyped (7 in FADS1, 5 in FADS2, 3 in ELOVL2 and 2 in ELOVL5). Minor allele carriers of rs174545, rs174546, rs174548 and rs174553 (FADS1), and rs1535 and rs174583 (FADS2) were nominally associated with an increased risk of having a BMI≥25. Only for the normal-weight group, minor allele carriers of rs174537, rs174545, rs174546, and rs174553 (FADS1) were negatively associated with AA:DGLA index. Normal-weight women who were minor allele carriers of FADS SNPs had lower levels of AA, AA:DGLA and AA:LA indexes, and higher levels of DGLA, compared to major homozygotes. Among minor allele carriers of FADS2 and ELOVL2 SNPs, overweight/obese women showed higher DHA:EPA index than the normal-weight group; however, they did not present higher DHA concentrations than the normal-weight women. In conclusion, minor allele carriers of FADS SNPs have an increased risk of obesity. Maternal weight changes the effect of genotype on FA levels. Only in the normal-weight group, minor allele carriers of FADS SNPs displayed reduced enzymatic activity and FA levels. This suggests that women with a BMI≥25 are less affected by FADS genetic variants in this regard. In the presence of FADS2 and ELOVL2 SNPs, overweight/obese women showed higher n-3 LC-PUFA production indexes than women with normal weight, but this was not enough to obtain a higher n-3 LC-PUFA concentration.

Citing Articles

Effect of FADS1 SNPs rs174546, rs174547 and rs174550 on blood fatty acid profiles and plasma free oxylipins.

Rabehl M, Wei Z, Leineweber C, Enssle J, Rothe M, Jung A Front Nutr. 2024; 11:1356986.

PMID: 39021601 PMC: 11253720. DOI: 10.3389/fnut.2024.1356986.


Genetic association between FADS and ELOVL polymorphisms and the circulating levels of EPA/DHA in humans: a scoping review.

Loukil I, Mutch D, Plourde M Genes Nutr. 2024; 19(1):11.

PMID: 38844860 PMC: 11157910. DOI: 10.1186/s12263-024-00747-4.


Patterns of perinatal polyunsaturated fatty acid status and associated dietary or candidate-genetic factors.

Abou Assi A, Heude B, Plancoulaine S, Sarte C, Tafflet M, Yuan W J Lipid Res. 2024; 65(6):100562.

PMID: 38762122 PMC: 11231547. DOI: 10.1016/j.jlr.2024.100562.


Genetic correlation between circulating metabolites and chalazion: a two-sample Mendelian randomization study.

Zhang X, Cai Y, Jiang Y, Du W, An W, Fu Q Front Mol Biosci. 2024; 11:1368669.

PMID: 38577173 PMC: 10991826. DOI: 10.3389/fmolb.2024.1368669.


Gestational Weight Gain: Is the Role of Genetic Variants a Determinant? A Review.

Samano R, Martinez-Rojano H, Chico-Barba G, Gamboa R, Mendoza-Flores M, Robles-Alarcon F Int J Mol Sci. 2024; 25(5).

PMID: 38474283 PMC: 10932001. DOI: 10.3390/ijms25053039.


References
1.
Inoue K, Kishida K, Hirata A, Funahashi T, Shimomura I . Low serum eicosapentaenoic acid / arachidonic acid ratio in male subjects with visceral obesity. Nutr Metab (Lond). 2013; 10(1):25. PMC: 3606329. DOI: 10.1186/1743-7075-10-25. View

2.
Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y . Effects of serum n-3 to n-6 polyunsaturated fatty acids ratios on coronary atherosclerosis in statin-treated patients with coronary artery disease. Am J Cardiol. 2012; 111(1):6-11. DOI: 10.1016/j.amjcard.2012.08.038. View

3.
Larque E, Gil-Sanchez A, Prieto-Sanchez M, Koletzko B . Omega 3 fatty acids, gestation and pregnancy outcomes. Br J Nutr. 2012; 107 Suppl 2:S77-84. DOI: 10.1017/S0007114512001481. View

4.
Martino J, Sebert S, Segura M, Garcia-Valdes L, Florido J, Padilla M . Maternal Body Weight and Gestational Diabetes Differentially Influence Placental and Pregnancy Outcomes. J Clin Endocrinol Metab. 2015; 101(1):59-68. PMC: 4701853. DOI: 10.1210/jc.2015-2590. View

5.
Lattka E, Illig T, Heinrich J, Koletzko B . Do FADS genotypes enhance our knowledge about fatty acid related phenotypes?. Clin Nutr. 2009; 29(3):277-87. DOI: 10.1016/j.clnu.2009.11.005. View